FDA Issues Warning Letter to Abbott Diabetes Care
February 04, 2026
February 04, 2026
WASHINGTON, Feb. 4 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Abbott Diabetes Care Inc. from the Center for Devices and Radiological Health:
* * *
Recipient: Christopher Scoggins, Executive Vice President of Diabetes Care, Abbott Diabetes Care, Inc., 1360 S Loop Rd, Alameda, CA 94502-7000, United States, (b)(4)
Issuing Office: Center for Devices and Radiological Health, United Stat . . .
* * *
Recipient: Christopher Scoggins, Executive Vice President of Diabetes Care, Abbott Diabetes Care, Inc., 1360 S Loop Rd, Alameda, CA 94502-7000, United States, (b)(4)
Issuing Office: Center for Devices and Radiological Health, United Stat . . .